New drug application accepted by FDA for GSK’s momelotinib
Therapy for the treatment of myelofibrosis has received significant results from phase 3 trial [...]
Thu, Aug 18, 2022
Chiesi’s Trimbow recommended for use within NHS Scotland
The SMC approval brings much-needed boost to asthma sufferers across Scotland [...]
Thu, Aug 18, 2022
Sanofi provides update on amcenestrant
The company's clinical development programme is to be discontinued following a recent evaluation [...]
Wed, Aug 17, 2022
LifeArc and Great Ormond Street Hospital charity award £1.3m to tackle diseases
Funds will allow researchers to focus on improving the lives of children with rare conditions [...]
Wed, Aug 17, 2022

 

The Learning  Partnership